KẾT QUẢ PHẪU THUẬT FREY ĐIỀU TRỊ VIÊM TỤY MẠN TẠI BỆNH VIỆN E

Abstract

Objective: To evaluate the outcomes of the Frey procedure in the treatment of chronic pancreatitis at the Department of General Surgery, E Hospital, during the period 2019–2025. Methods: A descriptive observational study was conducted on 35 patients with chronic pancreatitis who underwent the Frey procedure at the Department of General Surgery, E Hospital, between October 2019 and January 2025. Results: The mean age of the patients was 53.7 years; males accounted for 74.3%. The main etiologies were alcohol consumption (68.6%) and smoking (57.1%). All patients had pancreatic head stones; 85.7% had main pancreatic duct stones, and 42.9% had pseudocysts. The mean operative time was 215 ± 54 minutes, with an average blood loss of 65.4 ± 42.7 ml, and no intraoperative complications were recorded. Early postoperative complications occurred in 20% of patients, mainly Clavien–Dindo grade I–II, with no severe complications or mortality. At 6 months postoperatively, the Izbicki pain score decreased from 50.1 to 14.3, and the VAS score from 61.7 to 11.4 (p < 0.001). The overall SF-12 score increased from 30.3 to 76.1, and mean body weight increased by 3.9 kg. No severe late complications or mortality were observed during follow-up. Conclusion: The Frey procedure is a safe and effective treatment option for chronic pancreatitis with pancreatic duct dilatation, leading to significant improvement in quality of life and a low complication rate.